|
|
|
Insider
Information: |
Balo Andrew K |
Relationship: |
EVP Regulatory Strateg... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
50,908 |
|
Indirect Shares
|
30,212 |
|
|
Direct
Value |
$5,934,346 |
|
|
Indirect Value
|
$3,521,813 |
|
|
Total
Shares |
81,120 |
|
|
Total
Value |
$9,456,158 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
90.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-06-11 |
4 |
OE |
$8.94 |
$89,400 |
D/D |
10,000 |
166,483 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-06-25 |
4 |
AS |
$40.60 |
$405,982 |
D/D |
(10,000) |
159,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-06-25 |
4 |
OE |
$8.94 |
$89,400 |
D/D |
10,000 |
169,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-07-11 |
4 |
AS |
$35.93 |
$359,347 |
D/D |
(10,000) |
159,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-07-11 |
4 |
OE |
$8.94 |
$89,400 |
D/D |
10,000 |
169,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-07-25 |
4 |
OE |
$8.94 |
$89,400 |
D/D |
10,000 |
169,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-07-25 |
4 |
AS |
$38.19 |
$381,857 |
D/D |
(10,000) |
159,099 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-08-11 |
4 |
AS |
$44.24 |
$442,373 |
D/D |
(10,000) |
159,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-08-11 |
4 |
OE |
$8.94 |
$89,400 |
D/D |
10,000 |
169,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-08-22 |
4 |
S |
$44.24 |
$884,722 |
D/D |
(20,000) |
159,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-08-22 |
4 |
OE |
$3.19 |
$63,800 |
D/D |
20,000 |
179,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and ClinicalSV |
|
2014-08-25 |
4 |
AS |
$44.12 |
$441,243 |
D/D |
(10,000) |
159,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and ClinicalSV |
|
2014-08-25 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
169,205 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-10 |
4 |
D |
$43.23 |
$201,937 |
D/D |
(4,671) |
154,534 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-11 |
4 |
AS |
$42.97 |
$429,706 |
D/D |
(10,000) |
154,534 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-11 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
164,116 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-12 |
4 |
D |
$43.36 |
$190,968 |
D/D |
(4,404) |
150,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-25 |
4 |
AS |
$40.71 |
$407,072 |
D/D |
(10,000) |
150,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-09-25 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
160,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-10-13 |
4 |
AS |
$40.42 |
$404,165 |
D/D |
(10,000) |
150,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-10-13 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
160,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-10-27 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
160,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-10-27 |
4 |
AS |
$42.98 |
$429,755 |
D/D |
(10,000) |
150,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-11-11 |
4 |
AS |
$52.93 |
$529,295 |
D/D |
(10,000) |
150,130 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, Regulatory and Clinical |
|
2014-11-11 |
4 |
OE |
$7.63 |
$76,300 |
D/D |
10,000 |
160,130 |
0 |
- |
|
200 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|